Bayer | BAYN - Current Liabilities


Bayer reported EUR33.46B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Air Liquide EUR 8.76B 778.1M Dec/2025
Akzo Nobel EUR 4.39B 180M Mar/2026
Alcon AG USD 3B 45M Mar/2026
Amarin USD 179.64M 14.82M Mar/2026
Arkema EUR 2.15B 108.8M Mar/2026
AstraZeneca USD 32.57B 1.95B Mar/2026
BASF EUR 16.41B 838M Dec/2025
Bayer EUR 33.46B 875M Mar/2026
Beiersdorf EUR 3.51B 261M Dec/2025
Corteva USD 11.85B 271M Mar/2026
Covestro EUR 3.87B 299M Dec/2025
Essilor EUR 12.15B 766M Dec/2025
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
Genmab DKK 1.43B 686M Dec/2025
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
GRIFOLS EUR 2.12B 105M Mar/2026
Henkel EUR 8.42B 122M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Johnson Matthey GBP 2.53B 211M Jun/2026
Linde USD 15.39B 193M Mar/2026
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.35B 307M Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Nutrien USD 13.3B 2.26B Mar/2026
Philips EUR 7.43B 78M Mar/2026
PPG Industries USD 4.95B 53M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
SAP EUR 20.82B 3.57B Mar/2026
Solvay EUR 1.79B 59M Mar/2026
UCB EUR 4.4B 470M Dec/2025
Umicore EUR 4.25B 720.8M Dec/2025
Vinci EUR 58.1B 619M Dec/2025